Novel Laboratories, Inc. d.b.a LUPIN
Novel Laboratories, Inc. d.b.a LUPIN appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0726-2021, Class II) was initiated on July 29, 2021.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0726-2021 | Class II | GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured | July 29, 2021 |